Vol. 3  Iss.5 
The Chemical Educator 
© 1998 Springer-Verlag New York, Inc. 
ISSN 1430-4171
S 1430-4171 (98) 05245-1 
Book Review
 

NO: a novel by Carl Djerassi

 Reviewed by
George B. Kauffman, Laurie M. Kauffman, and Rowena Rege
California State University, Fresno, Fresno CA 93740-0070
george_kauffman@csufresno.edu
rege@oneworldconnect.com
 

NO: a novel by Carl Djerassi The University of Georgia Press, 330 Research Drive, Athens, GA 30602; London, 1998. xiii + 276 pp. 14.0 x 22.8 cm. $24.95 (hardcover), ISBN 0-8203-2032-3.


Is Carl Djerassi an academic chemist, an industrial chemist, or a creative writer? The answer: All three! The author of more than 1200 scientific publications and eight monographs, Djerassi is the recipient of numerous awards such as the 1973 U.S. National Medal of Science (for the first oral contraceptive), the 1991 U.S. National Medal of Technology (for novel approaches to insect control), the 1992 Priestley Medal (the American Chemical Society's highest award), the 1997 Willard Gibbs Medal of the ACS Chicago Section, and Sigma Xi's 1998 William Procter Prize for Scientific Achievement (to be awarded at the society's annual meeting this coming November in Vancouver, British Columbia). He is the founder of the Djerassi Resident Artists Colony near San Francisco that to date has supported almost a thousand artists in various disciplines, including Nobel chemistry laureate Roald Hoffmann as a three-time poet in residence. Djerassi is an avid art collector and Professor of Chemistry at Stanford University. After a half-century of dual research careers in industry and academe, Djerassi, like chemist–spectroscopist–novelist C. P. Snow, has embarked on a third career in creative writing, which we have followed with a mixture of growing interest, admiration, and anticipation [1].

Djerassi's new career was catalyzed by two brushes with death—the 1978 suicide of his daughter Pamela, an artist, which led to his founding of the Artists Colony, and his 1985 cancer surgery, both of which brought him to terms with his own mortality and convinced him that time was a precious commodity. His nonresearch writings include individual and collected short stories [2], poetry [3], autobiography [4, 5], essays [6], a television and videocassette program [7], a novel [8], and a tetralogy of novels [9–11] which exemplify what he calls "science-in-fiction" to differentiate it from the better-known science fiction. In this genre, which he uses to "make comprehensible [to nonscientists] the culture and behavior of scientists—uncommon in contemporary fiction," most of his characters, fictional as well as real, are scientists, and "everything [he specifies] does or could exist."

Cantor's Dilemma [9], the first novel in the tetralogy, dealt with the themes of trust, ambition, the mentor–protégé relationship, and women in science. The Bourbaki Gambit [10], the second novel, a fictionalized account of the development of the Nobel Prize-winning polymerase chain reaction (PCR), concerned scientists' passionate desire for recognition by their peers, the inherent collegiality of science, and the "graying" of Western science as prominent scientists age and face the prospect of retirement. Menachem's Seed [11], the third and shortest novel, treated the ethical question of whether or not a woman has a right to appropriate without consent the discarded sperm of a man who believes himself to be infertile in order to achieve pregnancy via today's "miracle techniques" (Djerassi currently teaches "Ethical Discourse through Science-in-Fiction" [Medicine 256], a graduate course offered under the auspices of the Center for Biomedical Ethics of Stanford University's School of Medicine [12]). In this seminar students write short stories dealing with the moral complexities of science; one of these stories appeared in a recent issue of Chemical and Engineering News [13], the first time in its 75-year history that the magazine has published a short story.

Because the conclusion of Menachem's Seed left a number of issues unresolved, we eagerly anticipated the publication of the last novel of his tetralogy, NO, a title that stands for both the simple negative expletive and the chemical formula for nitric oxide, the simple diatomic species that was named "Molecule of the Year" by the multidisciplinary journal Science in 1992. Nitric oxide plays a complicated and sophisticated role in the human body, where it serves as a chemical messenger in a wide variety of functions, including penile erection, leading to its use in the treatment of male impotence (euphemistically called erectile dysfunction), which Djerassi has used in NO as the vehicle for illustrating the role of a biotechnology company in contemporary biomedical research. Thus, although it has been involved in the previous novels, here, as in Menachem's Seed, sex—more precisely, human male reproduction—occupies center stage. (In his more than four decades of research and teaching, Djerassi has devoted himself to reproductive biology with emphasis on female contraception.)

As in the earlier novels, Djerassi offers the reader many insights into various topics of interest to different readers. For those concerned with gender issues he discusses intermarriage; feminism; single motherhood; the "glass ceiling" encountered by women in the professions; a woman's "biological clock;" the overwhelmingly patriarchal clan culture in which his characters live, work, and interact; the difficulties that a professional woman faces in balancing work, marriage, and family; and the urgent need for suitable role models for women contemplating scientific careers. For entrepreneurs interested in starting up a small biotech company, he considers the raising of cash, investment, venture capitalism, selection of board and committee members, stock options, IPOs, secondary offerings, underwriter wheeling and dealing, incentives, the manipulating power of financial analysts and journalists, networking, clinical trials, manufacturing, marketing, research and development, FDA regulations, the American regulatory bureaucracy, frivolous class-action suits, and class-action shysters. For scientists he deals with issues such as tenure, grantsmanship, academic-–industrial interactions, apportionment of credit among authors, competition, the National Academy of Sciences and other organizations; the need (Djerassi characterizes it as "lust") for validation, recognition, and awards (especially the Nobel Prize) that is both the nourishment and detriment of a creative mind; the tribal nature of the research scientist's culture and mores; the dependence of scientific reputation on the approbation of the researcher's peers; and the relationship of creative and sexual energy. The reader will also be enlightened on myriad fascinating topics such as the Bible; the Koran; music; opera; religious conversion; Jewish laws, customs, and holidays; and, of course, the practice of science itself.

In addition to describing how that subculture of small, entrepreunerial, research-driven enterprises known collectively as the biotech industry exists in an uneasy relationship with contemporary science, Djerassi returns to another of his principal concerns, "the historic marginalization of women in the male-dominated scientific universe and the attempts of modern women, as well as some men, to change this state of affairs" (p xi). It is not surprising that the developer of the first oral contraceptive, "one of the single greatest liberating influences for women," should be an ardent feminist, a conversion fostered by his third and present wife, Diane Middlebrook, Distinguished Professor of English at Stanford. In fact, although Djerassi has been called the "Father of the Pill;" he prefers the appellation "Mother of the Pill." Thus most of his female characters are strong, independent, take-charge women such as Melanie Laidlaw in Menachem's Seed and Renu Krishnan in NO.

The emphasis on the female perspective and point of view is especially evident in NO. All of the 30 episodes of stream-of-consciousness thoughts (set in italics) that provide flashbacks, fantasies, and character motivation are those of either Renu (28) or Melanie (2). Similarly, all of the 12 letters are those of Renu (11 to her brother Ashok in Bangalore, India's Silicon Valley) or Melanie. Melanie’s letter is written to her former lover Menachem Dvir, a vice president at the Ben-Gurion University in Beersheba and a married man who believes he was rendered infertile by exposure to radiation. In the letter she reveals how she stole his sperm (Menachem's Seed) to use in intracytoplasmic sperm injection (ICSI), the revolutionary fertilization technique of the early 1990s involving injection of a single sperm into an egg. The letter is reproduced in NO (pp 84–89) from Menachem's Seed (pp 177–185), thus directly linking the third and fourth novels. All together, these items of female thoughts and musings comprise almost a third of NO.

But in NO Djerassi has also combined the theme of the woman in science with that of another recent phenomenon, "the remarkable Asianization of the American academic research laboratory." As is well known, at many American universities the majority of graduate students in certain disciplines are Asians. Djerassi feels that although Indian women do not suffer most of the language problems encountered by Chinese or Japanese scientists working in the United States, they, like all Asian women in contemporary American science, are triply marginalized: "as women in a historically male-dominated field, as foreigners of color (even should they become naturalized citizens) and, finally, coming as they do from a culture in which a woman's role is clearly defined, by the process of eventually losing part of their native culture without gaining an acceptable new one" (p xii). Consequently, although she was only a minor character in Menachem's Seed, Djerassi has made Renu the prototypical protagonist of NO, in which she "confronts in a pressing personal form the problem of bridging gaps between widely divergent subcultures that has been the challenge facing all my characters — and especially me, the immigrant scientist [Djerrasi was born on Oct. 29, 1923 in Vienna, Austria and raised in Vienna and Sofia, Bulgaria before emigrating to the United States in 1939] turned fiction writer in his adopted language" (p xii).

In Menachem's Seed and NO, which take place in the pre-Viagra era and involve many of the same characters, Renu, who had emigrated from Madras in her native India, had graduated from Wellesley College, and had received her Ph.D. from Stanford University, became a postdoc of Dr. Felix Frankenthaler at Brandeis University's Rosenstiel Basic Medical Sciences Research Center where she discovered how NO is produced in the body and its role in vasodilation. Supported by a grant from Dr. Melanie Laidlaw, the widow of a prominent Columbia University biochemist and the American director of REPCON (Reproduction and Contraception), a foundation supporting research in reproductive biology, Renu travels to Jerusalem to work on clinical applications of synthetic NO-releasers (NONOates) with Dr. Yehudah Davidson of the Hadassah Medical Center, who sends her to Ben-Gurion University at Beersheba to work with bioengineer Dr. Jephtah Cohn, a secular Jew obsessed with his mamzerut (illegitimate birth status), on possible devices for delivering NO to the penis by means of his MUSA (medicated unit for sexual arousal).

In NO Renu and Jephtah become romantically involved, marry, and eventually have a daughter, Naomi, and a son, Ravi. Renu rises to the presidency of SURYA, Inc., a company (named after the Hindu sun god) formed to produce and market their products. She sells part of her stock to subsidize her husband's company, OV, Inc., and its subsidiary, Radha, named after the Hindu deity Krishna's favorite gopi (cowgirl), to manufacture and market his Tele-Ov, a vaginal diagnostic device to determine the time of ovulation. Renu, having tasted power (she tells her brother that "executive power does not 'turn me on'") and having made millions, resigns her presidency to "return to her roots as a scientist." She devotes herself to industrial biochemical research "to once more start with a basic scientific observation and to carry it all the way to final application in man—a process that is impossible in a university" (p 272). Not forgetting her Indian roots and knowing that "some of the most dramatic applications of nitric oxide are in parasitology and tropical diseases" and that big drug firms are "not interested in the comparatively unprofitable market represented by the poor of the Third World," she decides to seek cures for diseases caused by parasites that are highly vulnerable to nitric oxide.

Woman and her psyche have always been somewhat of a mystery to the opposite sex, as evidenced by Sigmund Freud's famous question, "Was will das Weib?" (What does woman want?). This mystery has been acknowledged by women as well as men. As a case in point, the 19th-century French scientist and "feminist" (the term was not yet invented) Clémence Royer, in a suppressed communication titled "Sur la natalité," told her colleagues at the Société d'Anthropologie, "to understand woman, it is necessary first not to be a man" [13]. And, a best-selling book by John Gray is titled Men are from Mars, Women Are from Venus.

Thus it is not surprising that the number of male authors who have successfully captured the female perspective is extremely small. The names of Henry James, whose reputation rested on his realistic depiction of "the American girl," D. H. Lawrence of Lady Chatterly's Lover fame, and James Joyce, whose Ulysses concludes with Molly Bloom's long affirmative soliloquy, are among the few on this list. Yet, apparently believing in Robert Browning's dictum, "A man's reach should exceed his grasp," Djerassi, a seasoned scientist and entrepreneur but a relative newcomer to creative writing, deserves credit for daring to attempt this challenging feat.

In addition to characters from Menachem's Seed, persons from Djerassi's other earlier "science-in-fiction" novels reappear in this concluding volume, especially as members of SURYA's scientific and medical advisory boards: from The Bourbaki Gambit, Max Weiss, retired Princeton biochemist; and from Cantor's Dilemma, Nobel laureate Isidore Cantor; Jeremiah Stafford, Cantor’s student and fellow Nobel laureate; Paula Curry, who marries Cantor; and Celestine Price, a Cal Tech researcher and Paula's niece. As usual in Djerassi's novels, there is a large cast of interesting characters and the occasional mention of real people, e.g., John Maddox, former editor of the international scientific journal Nature; Mother Teresa, who blesses SURYA's prospectus by autographing it; and Judge Marilyn Hall Patel, who is asked to rule in a lawsuit involving SURYA. And sitting on SURYA's board of directors is Alfredo Zaffanori, founder of ZALA laboratories and an authority on drug delivery systems—obviously a thinly disguised Alejandro Zaffaroni of ALZA laboratories. (The book is dedicated to George Rosenkranz and Zaffaroni, technical director and executive vice president, respectively of Syntex, with whom Djerassi was associated as research vice president and board member.) Djerassi even mentions himself twice—first, with his typical humor, in connection with the awarding of the first Wolf Prizes at the Knesset in Jerusalem (Renu, who witnessed the ceremony, writes Frankenthaler, "Chemistry had a single winner with a crazy spelling.... A good speaker, but a bit arrogant, I would say" [pp 13–14]) and second, in connection with his Stanford human biology course, "Feminist Perspectives on Birth Control" (pp 203–204).

In the concluding sentences of NO and hence of the tetralogy, Djerassi underscores one of his favorite themes with a conversation between Celestine Price and Renu:

"Now that you're moving back to the lab? Do you lust?" [Celestine asks] ..."I suppose I do," Renu said. "I think Cantor was right: noble science usually goes with lusting for recognition; one of those gray aspects of science he spoke about. Why are you looking at me that way? Are you disappointed?" "Disappointed?" Celestine shook her head. "On the contrary. I'm relieved. Welcome to the tribe" (p 276). In Menachem's Seed, Djerassi's characters, particularly the women such as Melanie Laidlaw, were fully developed characters about whom we grew to care and with whom we came to empathize. In NO, however, Renu, in a sense Djerassi's alter ego (like her, he was intimately involved in drug development and venture capitalism with CIBA in Summit, NJ and Syntex, S.A. in Mexico City.), seems to be a character more designed to serve his purpose of demonstrating that an immigrant Asian woman can succeed in a primarily male-dominated field than a fully developed real person. Yet, especially in his masterly treatment of the details of the scientific aspects of his "science-in-fiction" novels, which, after all, are their raison d'être, Djerassi writes with the authority of a longtime insider and participant. We are extremely pleased to observe the progress that Djerassi has made in his fiction writing.

Because the amount of basic science as well as research, development, and marketing in this novel is much more than in the previous three, the book may have more appeal to scientists, particularly those involved in industry and entrepreneurship, than to the general public. Nevertheless, since Djerassi continues to write about what he knows best, it is autobiographical and self-revealing. As in Menachem's Seed, in NO Djerassi speaks fully in his own distinctive voice.

In his now-completed tetralogy of "science-in-fiction" novels Djerassi has successfully depicted the human side of scientists and the personal conflicts that they face in their quest for scientific knowledge, personal recognition, and financial rewards as well as simultaneously describing with a high degree of accuracy some exciting current biomedical developments. Not content to rest on his laurels, however, he has embarked on a projected trilogy of stage plays to explore the even rarer genre of "science-in-theatre." The world premiere of Djerassi's first play in this genre, ICSI: An Immaculate Misconception, based on Menachem's Seed, produced and directed by William Archer, was held on August 6, 1998 at the Edinburgh Fringe Festival in Edinburgh, Scotland. A live video of an actual insertion of a single sperm into an egg is incorporated into the play, which will run there through August 31, 1998. It is likely that it will subsequently open in London. Organon, the Dutch pharmaceutical company, is underwriting a performance of the Edinburgh production with the Edinburgh cast in San Francisco at the International Congress on Reproductive Medicine, where a symposium on ICSI will be held. Djerassi is currently working on the second play of the trilogy, NO, loosely based on some aspects of the novel under review here. For further details on Djerassi's "science-in-fiction" and "science-in-theatre" as well as excerpts from his novels, visit his web site: http://www.djerassi.com.

REFERENCES

1. Kauffman, G. B.; Kauffman, L. M. "The Steroid King;" The World & I 1992, 7(7), 312.

2. Djerassi, C. The Futurist and Other Short Stories; Futura/Macdonald: London, 1988.

3. Djerassi, C. The Clock Runs Backward; Story Line Press: Brownsville, Oregon, 1991; Kauffman, G. B.; Kauffman, L. M. Chem. Br. 1992, 28, 919.

4. Djerassi, C. Steroids Made It Possible; American Chemical Society: Washington, D.C., 1990; Kauffman, G. B. Am. Scientist 1992, 80, 190.

5. Djerassi, C. The Pill, Pygmy Chimps, and Degas' Horse: The Autobiography of Carl Djerassi; HarperCollins: New York, 1992; Kauffman, G. B.; Kauffman, L. M. J. Chem. Educ. 1993, 70, A53.

6. Djerassi, C. From the Lab into the World: A Pill for People, Pets, and Bugs; American Chemical Society: Washington, D.C., 1994; Kauffman, G. B.; Kauffman, L. M. J. Chem. Educ. 1995, 72, A109.

7. Djerassi, C. The Atom That Makes the Difference: A Scattering of Ashes (Carbon); Films for the Humanities and Sciences: Princeton, N. J., 1991; Kauffman, G. B.; Kauffman, L. M. J. Chem. Educ. 1993, 70, A53.

8. Djerassi, C. Marx, Deceased; University of Georgia Press: Athens, GA., 1996; Kauffman, G. B.; Kauffman, L. M. Chem. Intelligencer 1997, 3 (3), 55. Since this novel is not part of the "science-in-fiction" tetralogy, it does not deal with the tight-knit tribal culture of scientists of the tetralogy but with the equally insular working lives of writers, who, being human beings, share many of the same common characteristics and concerns of scientists, another of Djerassi's themes.

9. Djerassi, C. Cantor's Dilemma; Doubleday: New York, 1989; Kauffman, G. B.; Kauffman, L. M. Angew. Chem., Int. Ed. Engl. 1990, 20, 1488.

10. Djerassi, C. The Bourbaki Gambit; The University of Georgia Press: Athens, GA., 1994; Kauffman, G. B.; Kauffman, L. M. Chem. Heritage 1995-96, 13(1), 15.

11. Djerassi, C. Menachem's Seed; The University of Georgia Press: Athens, GA., 1997; Kauffman, G. B.; Kauffman, L. M. J. Chem. Educ. 1998, 75, in press.

12. Djerassi, C. Science 1998, 393, 511.

13. Lin, S. Chem. & Eng. News July 27, 1998, 76 (30), 59.

14. Harvey, J. "Almost a Man of Genius": Clémence Royer; Feminism, and Nineteenth-Century Science; Rutgers University Press: New Brunswick, N.J., 1997; p 195.